Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001501853 | SCV001706671 | likely benign | not provided | 2023-06-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002563338 | SCV003696188 | uncertain significance | Inborn genetic diseases | 2024-04-26 | criteria provided, single submitter | clinical testing | The c.2722C>T (p.P908S) alteration is located in exon 21 (coding exon 21) of the AARS2 gene. This alteration results from a C to T substitution at nucleotide position 2722, causing the proline (P) at amino acid position 908 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV001501853 | SCV005201405 | uncertain significance | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |